logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

NSCLC surgery after neoadjuvant atezolizumab, chemotherapy

Almost 90% of patients had R0 resection after neoadjuvant treatment.